• facebook
  • linkedin
  • youtube

Ukuvela kwe-SARS-CoV-2 B.1.1.7 Lineage-

E-United States, Disemba 29, 2020-Januwari 12, 2021

Ehlobo E. Galloway, PhD 1;Prabasaj Paul, PhD 1;Duncan R. MacCannell, PhD 2;UMichael A. Johansson, PhD 1;

UJohn T. Brooks, MD 1;U-Adam MacNeil, PhD 1;Rachel B. Slayton, PhD 1;Suxiang Tong, PhD 1;Benjamin J. Silk, PhD 1;Gregory L. Armstrong, MD 2;

Matthew Biggerstaff, iScD 1;U-Vivien G. Dugan, PhD

NgoJanuwari 15, 2021, lo mbiko wathunyelwa njenge-MMWRUkukhishwa Ngaphambi kwesikhathi kuwebhusayithi ye-MMWR (https://www.cdc.gov/mmwr).

NgoDisemba 14, 2020, i-United Kingdom yabikaokuhlukile kwe-SARS-CoV-2 yokukhathazeka (VOC), uzalo B.1.1.7,ebizwa nangokuthi i-VOC 202012/01 noma 20I/501Y.V1.*B.1.1.7 okuhlukile kulinganiselwa ukuthi kwavela ngoSepthemba2020 futhi isibe yisona esihamba phambili ngokusheshaOkuhlukile kwe-SARS-CoV-2 e-England (1).B.1.1.7 kubekutholwe emazweni angaphezu kuka-30, kuhlanganise ne-United States.Njengobayango-January 13, 2021, cishe izigameko ezingu-76 ze-B.1.1.7 zinekutholwe ezifundazweni eziyi-12 zase-US.Imigqa eminingi yobufakazizikhombisa ukuthi i-B.1.1.7 isakazwa ngendlela ephumelela kakhulu kunaleyoezinye izinhlobo ze-SARS-CoV-2 (1-3).I-trajectory enemodeli yelokhu okuhlukile e-US kubonisa ukukhula okusheshayo ekuqaleni kuka-2021,ibe yinhlobonhlobo ehamba phambili ngoMashi.KwandiswaUkudluliselwa kwe-SARS-CoV-2 kungase kusongela ukunakekelwa kwezempilo okuqinileizinsiza, zidinga ukuqaliswa okunwetshiwe nokuqine kakhuluzamasu ezempilo yomphakathi (4), futhi andise amaphesentiUkuvikeleka kwesibalo sabantu kuyadingeka ekulawuleni ubhubhane.Ukuthathaizinyathelo zokunciphisa ukudluliswa manje zinganciphisa amandlaumthelela we-B.1.1.7 futhi uvumele isikhathi esibalulekile sokwandisa umgomoukusabalala.Ngokuhlangene, ukubhekwa kwe-genomic okuthuthukisiwekuhlanganiswe nokuqhubeka nokulandela umphakathi ngempumeleloizinyathelo zempilo, okuhlanganisa ukugoma, ukuqhela ngokomzimba,ukusetshenziswa kwezifihla-buso, inhlanzeko yezandla, kanye nokuzihlukanisa kanye nokuvalelwa yedwa, kuzokwenzaKubalulekile ukunqanda ukusabalala kwe-SARS-CoV-2, igciwaneebangela isifo se-coronavirus 2019 (COVID-19).Amaqhingaukuhlolwa kwabantu abangenazo izimpawu kodwa abasengozini enkulu yokuukutheleleka, njengalabo abachayeke ku-SARS-CoV-2 noma abanayoukuxhumana njalo okungagwemeki nomphakathi, kunikeza okunyeithuba lokunciphisa ukusabalala okuqhubekayo.

I-Global genomic surveillance kanye ne-shar yomthombo ovulekile osheshayoUkulandelana kwe-viral genome kwenze kwaba lula ngesikhathi sangempelaukutholwa, ukuqhathanisa, kanye nokulandelelwa kokuvela kwe-SARS-CoV-2okuhlukile okungazisa imizamo yezempilo yomphakathi yokulawulaubhubhane.Nakuba ezinye izinguquko ku-genome yegciwaneukuphuma bese kuhlehla, abanye bangase banikeze i-advan ekhethiwetage kokuhlukile, okuhlanganisa ukudluliseka okuthuthukisiwe, ukuzeokuhlukile okunjalo kungabusa ngokushesha ezinye izinhlobo ezijikelezayo.

Ekuqaleni kwalolu bhubhane, izinhlobonhlobo ze-SARS-CoV-2 eziquketheukuguqulwa kwe-D614G kuphrotheni ye-spike (S) eyandayoukukhuthala kokubopha ama-receptor ngokushesha kwaba namandla kwabaningiizifunda zezwe (5,6).Ekupheleni kuka-2020, amazwe amaningi abike ukuthi atholileIzinhlobonhlobo ze-SARS-CoV-2 ezisabalala ngokuphumelelayo.Ngaphezu kwalokhokuya kokuhlukile kwe-B.1.1.7, okuhlukile okuphawulekayo kufaka phakathi i-B.1.351Uzalo lwaqala ukutholakala eNingizimu Afrika kanye nalolo olusanda kuhlonzwaB.1.1.28 isigatshana (seqanjwe kabushaP.1) kutholwe kubahambi abanekusuka eBrazil ngesikhathi sokuhlolwa okujwayelekile eHaneda (Tokyo)isikhumulo sezindiza.§ Lezi zinhlobonhlobo ziphethe umlaza we-genetic mutations, okufaka phakathi isizinda esibopha i-S protein receptor,okubalulekile ekubopheni i-angiotensin cell cell-ukuguqula i-enzyme-2 (ACE-2) receptor ukuze kube lula igciwaneukungena.Ubufakazi bubonisa ukuthi ezinye izinguquko ezitholakala kuleziokuhlukile kungase kunikeze hhayi kuphela ukwanda kokudluliseka kodwaingase futhi ithinte ukusebenza kwesinye isikhathi sangempela sokuxilongaukuhlehla okulotshiweyo-i-polymerase chain reaction (RT-PCR)ukuhlolafuthi unciphise amathuba okuba sengozini yokuqeda amasosha omzimba(2,3,5-10).Umbiko wecala wakamuva ubhale icala lokuqala leI-SARS-CoV-2 iphinde yatheleleka e-Brazil ngokuhlukile kwe-SARS-CoV-2ebiqukethe ukuguqulwa kwe-E484K,** okubonisiweukunciphisa ukungathathi hlangothi nge-convalescent sera kanye ne-monoclonalamasosha omzimba (9,10).

Lo mbiko ugxile ekuveleni kokuhluka kwe-B.1.1.7e-United States.Kusukela ngomhlaka-12 Januwari 2021, akukho noyedwaB.1.351 noma okuhlukile kwe-P.1 kutholwe ku-I-united states.Ukuze uthole ulwazi mayelana ne-SARS-CoV-2 abasafufusaIzinhlobonhlobo zokukhathazeka, i-CDC igcina ikhasi lewebhu elinikezelweukuhlinzeka ngolwazi ngezinhlobonhlobo ze-SARS-CoV-2 ezisafufusa.††

 B.1.1.7 uhlu lozalo (20I/501Y.V1)

Okuhlukile kwe-B.1.1.7 kuphethe ukuguqulwa kwephrotheni ye-S(N501Y) ethinta ukwakheka kokubopha kwama-receptorisizinda.Lokhu okuhlukile kunezinye ezingu-13 ze-B.1.1.7 lineage-definingmutations (Ithebula), eziningana zazo ziku-S protein,kufaka phakathi ukususwa ezikhundleni 69 kanye no-70 (del69-70) lokhokwavela ngokuzenzakalelayo kwezinye izinhlobo ze-SARS-CoV-2 futhi kunjalokucatshangelwe ukwandisa ukudluliseka (2,7).Ukususwaezikhundleni ezingu-69 nezingu-70 kubangela ukwehluleka kwethagethi ye-S-gene (SGTF)okungenani ku-RT-PCR eyodwa-i-diagnostic assay esekelwe (okungukuthi, nge-I-ThermoFisher Taq Path COVID-19 assay, i-B.1.1.7 variintuthwane nokunye okuhlukile nge-del69-70 akhiqiza negativeumphumela wethagethi ye-S-gene kanye nomphumela omuhle kwabanye ababiliokuhlosiwe);I-SGTF isebenze njengommeleli e-United Kingdomyokuhlonza B.1.1.7 amacala (1).Imigqa eminingi yobufakazi ikhombisa ukuthi i-B.1.1.7 ingaphezuluisakazwa kahle uma iqhathaniswa namanye ama-SARS-CoV-2izinhlobonhlobo ezijikelezayo e-United Kingdom.Izifunda zase-UK ngeingxenye ephezulu yokulandelana kwe-B.1.1.7 ibe nobhubhane olusheshayoukukhula kunezinye izindawo, ukuxilonga nge-SGTF kwandangokushesha kunokuxilonga okungeyona i-SGTF ezindaweni ezifanayo, kanye aingxenye ephezulu yabathintwayo yangenwa iziguli ezinenkombaabanezifo ezingu-B.1.1.7 kuneziguli ezinenkomba enazoezinye izinhlobo (1,3).Okuhlukile okungu-B.1.1.7 kunamandla okwandisa i-US pani-demic trajectory ezinyangeni ezizayo.Ukukhombisa lo mphumela,kwasungulwa imodeli yekhompathi elula enezinhlobonhlobo ezimbili.Ukuvama kwamanje kwe-US kwe-B.1.1.7 phakathi kwakho konke okujikelezayoamagciwane awaziwa kodwa kucatshangwa ukuthi <0.5% ngokususelwa ku-inombolo elinganiselwe yezigameko ezitholiwe kanye nedatha ye-SGTF (8).Ngobaimodeli, ukuqagela kokuqala kwakuhlanganisa ukusabalala kwe-B.1.1.7ka-0.5% kuzo zonke izifo, ukungatheleleki kwe-SARS-CoV-2 kusukaukutheleleka kwangaphambilini okungu-10%-I-30%, ukuzala okuhlukahluka kwesikhathiinombolo (R t) ka-1.1 (ukudluliselwa okuncishisiwe kodwa okukhulayo)noma 0.9 (ukwehla kokudluliselwa) kwezinhlobonhlobo zamanje, futhi kubikwe izehlakalo zamacala angama-60 kubantu abayi-100,000 ngosukuJanuwari 1, 2021. Lokhu kuqagela akumeli ngokunembilenoma iyiphi indawo yase-US, kodwa kunalokho, ikhombisa ukwenziwa okuvamile kweizimo ezijwayelekile ezweni lonke.Ushintsho ku-R t phezuisikhathi esibangelwa ukungatheleleki okutholiwe kanye nokwanda kwe-prevai-lence ye-B.1.1.7, yamodela, kwacatshangwa ukuthi i-B.1.1.7 R tukuze kube njalo izikhathi ezingu-1.5 i-R t yezinhlobonhlobo zamanje, ngokusekelwe kuizilinganiso zokuqala ezivela e-United Kingdom (1,3).Okulandelayo, umthelela ongaba khona wokugoma wamodelakucatshangwa ukuthi imithamo yokugoma eyisigidi esisodwa yanikezwa umuntu ngamunyeusuku oluqala ngoJanuwari 1, 2021, kanye nalokho kungavikeleki okungama-95%.kufinyelelwe ezinsukwini eziyi-14 ngemuva kokuthola imithamo emi-2.Ngokuqondile,ukungatheleleki ekuthelelekeni ngezinhlobonhlobo zamanje nomaB.1.1.7 okuhlukile kwacatshangelwa, nakuba ukusebenza ngempumelelo kanyeisikhathi sokuvikeleka ekuthelelekeni asiqiniseki,ngoba lezi bekungezona iziphetho eziyinhloko zokuhlolwa komtholampiloemithini yokugoma yokuqala.Kulo modeli, ukusabalala kwe-B.1.1.7 kuphansi ekuqaleni, nokho ngenxa yokuthiidluliseka kakhulu kunezinhlobonhlobo zamanje, iyabonisaukukhula okusheshayo ekuqaleni kuka-2021, kwaba ukuhlukahluka okuveleleintuthwane ngoMashi (Umfanekiso 1).Ukuthi ukudluliswa kwamanjeokuhlukile kuyanda (i-R t yokuqala = 1.1) noma kuncipha kancane(i-R t yokuqala = 0.9) ngoJanuwari, i-B.1.1.7 yenza ushintsho olukhulukumzila wokudlulisela kanye nesigaba esisha sokuchayekaukukhula.Ngomgomo ovikela ukutheleleka, iizindlela zobhubhane zakuqala azishintshi futhi B.1.1.7 ukusabalalakusenzeka (Umfanekiso 2).Nokho, ngemva B.1.1.7 ibaukuhluka okuvelele, ukudluliswa kwayo kwehliswe kakhulu.Umthelela wokugoma ekwehliseni ukusulelana esikhathini esiseduzeIsikhathi sasisikhulu kakhulu esimweni lapho ukudluliswa bekukhonakakade iyancipha (i-R t yokuqala = 0.9) (Umfanekiso 2).Imizamo yokuqala ukuthiingakhawulela ukusabalala kokuhluka kwe-B.1.1.7, okufana nendawo yonke kanyeukwanda kokuhambisana namasu okunciphisa impilo yomphakathi,kuzovumela isikhathi esengeziwe sokuthi ukugoma okuqhubekayo kufinyelele phezuluukungavikeleki kwezinga labantu.

Ingxoxo

Njengamanje, awukho umehluko owaziwayo emiphumeleni yomtholampilookuhlotshaniswa nokuhluka okuchazwe kwe-SARS-CoV-2;Nokho,izinga eliphezulu lokudlulisela lizoholela ezimweni eziningi, ukwandainani labantu bebonke abadinga ukunakekelwa komtholampilo, liyakhulaukwethula umthwalo ohlelweni lokunakekelwa kwezempilo oseluvele lunzima,futhi kubangele ukufa okwengeziwe.Ukubhekwa kwe-genomic okuqhubekayoukuhlonza amacala B.1.1.7, kanye nokuvela kwamanyeizinhlobonhlobo zokukhathazeka e-United States, kubalulekile ukuzeImpendulo yezempilo yomphakathi ye-COVID-19.Nakuba imiphumela ye-SGTFingasiza ekuhlonzeni izimo ezingaba khona ze-B.1.1.7 ezingaqinisekiswangokulandelanisa, ukukhomba okuhlukile okubalulekile okungabonisiI-SGTF ithembele ngokukhethekile ekugadeni okusekelwe ngokulandelana.

 

 

 

Igama elihlukile

Ukuhlonza kokuqala  

Ukuguqulwa kwesici

(amaprotheni: ukuguqulwa)

Inombolo yamacala amanje aqinisekisiwe ngokulandelana Cha

amazwe ane

ukulandelana

Indawo Usuku I-united states Emhlabeni jikelele  
B.1.1.7 (20I/501Y.V1) i-United Kingdom Septhemba 2020 I-ORF1ab: T1001I, A1708D, I2230T,

del 3675-Idatha ye-3677SGF

s: i69-70 HV, del144 Y, N501Y,

I-A570D, D614G, P681H, T761I,

I-S982A, D1118H

I-ORF8: Q27stop, R52I, Y73C

N: D3L, S235F

76 15,369 36
B.1.351 (20H/501Y.V2) Iningizimu Afrika Okthoba 2020 I-ORF1ab: K1655N

E: p71l

N: T205I

S:K417N, E484K, N501Y, D614G,

I-A701V

0 415 13

 

P.1 (20J/501Y.V3 Brazil kanye Japan Jan 2021 I-ORF1ab: F681L, I760T, S1188L,

K1795Q, del3675-3677 SGF, E5662D

S: L18F, T20N, P26S, D138Y, R190S,

I-K417T, E484K, N501Y, D614G,

I-H655Y, T1027I

I-ORF3a: C174G

I-ORF8: E92K

I-ORF9: Q77E

ORF14: V49L

N: p80R

0 35 2

 

Izifinyezo: del = ukususwa;E = amaprotheni emvilophu;N = amaprotheni e-nucleocapsid;ORF = uhlaka lokufunda oluvulekile;S = amaprotheni spike.

Okuhlangenwe nakho e-United Kingdom kanye namamodeli we-B.1.1.7okwethulwa kulo mbiko kukhombisa umthelela othathelana kakhuluokuhlukile kungaba nenani lezimo ngenani labantu.Iukwanda kokudluliselwa kwalokhu okuhlukile kudinga okwengeziweukuqaliswa okuhlangene okuqinile kokugoma kanye ne-mitigaizilinganiso ze-tion (isb., ukuqhela, ukufihla ubuso, nokuhlanzeka kwezandla)ukulawula ukusabalala kwe-SARS-CoV-2.Lezi zinyathelo zizobangempumelelo kakhulu uma ziqalwa ngokushesha kunokuba kamuvaukunciphisa ukusabalala kokuqala kokuhluka kwe-B.1.1.7.Imizamo yokulungisa uhlelo lokunakekelwa kwezempilo ukuze kuqhutshekwe nokuhlinzwa ezimenikuqinisekisiwe.Ukwenyuka kwe-transmissibility kusho ukuthi kuphezuluUkugoma okulindelwe kufanele kufinyelelweukufinyelela izinga elifanayo lokulawula izifo ukuze kuvikelwe umphakathiuma kuqhathaniswa nokwahluka okungadluliseki kancane.Ngokubambisana nezemfundo, imboni, isifunda, indawo,abahlanganyeli bezizwe, nabasekhaya, i-CDC nezinye izinhlaka zikahulumeniaxhumanisa futhi athuthukisa ukubhekwa kwe-genomic futhiimizamo yokuhlukanisa igciwane e-United States yonkana.I-CDCixhumanisa imizamo yase-US yokulandelanisa nge-SARS-CoV-2Ukulandelana Kwempendulo Ephuthumayo Yezempilo Yomphakathi,I-Epidemiology, kanye nokubhekwa (SPHERES)§§i-consortium,okuhlanganisa cishe izikhungo ezibamba iqhaza eziyi-170 futhi ikhuthaza ukwabelana ngedatha okuvulekile ukuze kube lula ukusetshenziswa kwe-SARS-CoV-2ukulandelana kwedatha.Ukuze ulandelele i-SARS-CoV-2 virus evolution, i-CDCukusebenzisa i-multifaceted genomic surveillance ukuqondai-epidemiologic, i-immunologic, kanye nezinqubo zokuziphendukela kwemveloezibumba i-viral phylogenies (phylodynamics);umhlahlandlela ukuqubukauphenyo;kanye nokwenza lula ukutholwa kanye nezimpawuukutheleleka okungenzeka kabusha, amacala okuphumelela ekugomeni, kanyeizinhlobo zegciwane ezivelayo.NgoNovemba 2020, i-CDC yasungulwauhlelo lukazwelonke lwe-SARS-CoV-2 Strain Surveillance (NS3).ukuthuthukisa ukumeleleka kwe-SARS-CoV-2 yasekhayaukulandelana.Uhlelo lusebenzisana nomphakathi wase-US ongu-64amalabhorethri ezempilo ukuze asekele uhlelo lokuhlola i-genomic;I-NS3 futhi yakha iqoqo lezibonelo ze-SARS-CoV-2 akanye nokulandelana kokweseka impendulo yezempilo yomphakathi kanye nezesayensiucwaningo lokuhlola umthelela ophathelene noguquko kuizinyathelo ezikhona ezinconyiwe zezokwelapha.I-CDC inakhofuthi wathola inkontileka nelabhorethri yezohwebo eminingana emikhuluama-tories ukulandelana ngokushesha amashumi ezinkulungwane ze-SARS-CoV-2-izibonelo ezinhle inyanga ngayinye futhi uxhase izifundo eziyisikhombisaizikhungo ukwenza ukubhekwa kwe-genomic ngokubambisananezikhungo zezempilo zomphakathi, ngaleyo ndlela zengeza kakhuluukutholakala kwedatha ye-genomic surveillance efika ngesikhathi evela kuyo yonke indawoI-the united states.Ngaphezu kwalezi zinhlelo zikazwelonke,izikhungo eziningi zezempilo zikahulumeni nezendawo ziyalandelana

UMFANEKISO 1. Izigameko ezilingisayo zezigameko* zokuhlukahluka kwamanje kwe-SARS-CoV-2 nokuhluka kwe-B.1.1.7,sicabange ukuthi akukho mgomo womphakathikanye nokuthi u-R t = 1.1 (A) noma u-R t = 0.9 (B) wezinto ezihlukile zamanje-United States, January-Ephreli 2021

 

umfanekiso 1
umfanekiso 2
izifinyezo
umfanekiso 1

I-SARS-CoV-2 ukuze uqonde kangcono i-epidemiology yendawo kanyeukusekela impendulo yezempilo yomphakathi kulo bhubhane.Okutholakele kulo mbiko kukhonjelwe okungenani emikhawulweni emithathuizithasiselo.Okokuqala, ubukhulu bokwanda kwe-transmissibile-United States uma kuqhathaniswa nalokho okubonwe kuI-United Kingdom isalokhu ingakacaci.Okwesibili, ukusabalala kweB.1.1.7 e-United States nayo akwaziwa ngalesi sikhathi, kodwaukutholwa kwezinhlobonhlobo kanye nokulinganisa kokuvama kuzothuthukangemizamo ethuthukisiwe yokuqapha yase-US.Ekugcineni, i-mitiga yendawoIzinyathelo ze-tion nazo ziyahlukahluka kakhulu, okuholela ekushintshashintsheniR t.Imiphumela ethize evezwe lapha isekelwe ku-simulafuthi acabange ukuthi akukho shintsho ekuncishisweni ngaphandle kukaJanuwari 1.Ukudluliselwa okukhulayo kwempi ehlukile engu-B.1.1.7iphakamisa ukuqaliswa ngokuqinile kwamasu ezempilo yomphakathi ukuzeukunciphisa ukudluliswa kanye nokunciphisa umthelela ongaba khona we-B.1.1.7,ukuthenga isikhathi esibalulekile sokwandisa ukutholakala kokugoma.I-CDC'Sidatha yokumodela ibonisa ukuthi ukusetshenziswa kwendawo yonke kanye nokwanda kokuhambisanaIzinyathelo zokunciphisa kanye nokugoma kubalulekileukunciphisa inani lamacala amasha nokufa kakhulu e-izinyanga ezizayo.Ngaphezu kwalokho, ukuhlolwa kwamasu kwabantu abangenawoizimpawu ze-COVID-19, kodwa abasengozini eyengeziweukutheleleka nge-SARS-CoV-2, kunikeza elinye ithuba lokunciphisa ukusabalala okuqhubekayo.Ngokuhlangene, ukubhekwa kwe-genomic okuthuthukisiwei-lance kuhlanganiswe nokwanda kokuhambisana nempilo yomphakathiamasu okunciphisa, okuhlanganisa ukugoma, ukuba kude ngokomzimbaukusetshenziswa kwezifihla-buso, inhlanzeko yezandla, ukuzihlukanisa nokuhlala yedwa,kuzobaluleka ukunciphisa ukusabalala kwe-SARS-CoV-2 kanyeukuvikela impilo yomphakathi.

Ukubonga

Amalungu Ochungechunge Lwezimo Eziphuthumayo Zezempilo YomphakathiI-Response, Epidemiology and Surveillance consortium;izwe kanye nendawoamalabhorethri ezempilo zomphakathi;Inhlangano YamaLabhorethri Ezempilo Yomphakathi;Ithimba le-CDC lokuphendula i-COVID-19;Igatsha Lamagciwane Okuphefumula,I-Division of Viral Diseases, i-CDC.Committee ye-Medical Journal Editors ifomu ukuze kudalulwe amandlaukungqubuzana kwezintshisekelo.Akukho ukungqubuzana kwezintshisekelo okungenzeka kudaluliwe.

Izithenjwa

1. Impilo Yomphakathi eNgilandi.Ukuphenywa kwenoveli ehlukile yakwa-SARS-CoV-2: okuhlukile kokukhathazeka 202012/01, isithangami sezobuchwepheshe 3. London, United Kingdom: Public Health England;2020. https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/950823/Variant_of_Concern_VOC_202012_01_Technical_Briefing_3_-_England.pdf
2. Kemp SA, Harvey WT, Datir RP, et al.Ukuvela okuvamile nokudluliswa kwe-SARS-CoV-2 spike deletion ΔH69/V70.bioRxiv[Preprint ithunyelwe ku-inthanethi Januwari 14, 2021].https://www.biorxiv.org/content/10.1101/2020.12.14.422555v4
3. Volz E, Mishra S, Chand M, et al.Ukudluliswa kohlu lozalo lwe-SARS-CoV-2 B.1.1.7 e-England: imininingwane evela ekuxhumaniseni idatha ye-epidemiological and genetic.medRxiv [Preprint ithunyelwe ku-inthanethi ngoJanuwari 4, 2021].https://www.medrxiv.org/content/10.1101/2020.12.30.20249034v2
4. Honein MA, Christie A, Rose DA, et al.;Ithimba lokuphendula le-CDC COVID-19.Isifinyezo somhlahlandlela wamasu ezempilo yomphakathi ukubhekana nezinga eliphezulu lokudluliswa komphakathi kwe-SARS-CoV-2 nokufa okuhlobene, Disemba 2020. I-MMWR Morb Mortal Wkly Rep 2020;69:1860–7.PMID:33301434 https://doi.org/10.15585/mmwre2mm.
5. Volz E, Hill V, McCrone JT, et al.;I-COG-UK Consortium.Ukuhlola imiphumela ye-SARS-CoV-2 spike ukuguqulwa kwe-D614G ekudluliselweni kwe-pathogenicity kanye ne-pathogenicity.Iseli 2021;184:64–75.e11.PMID:33275900 https://doi.org/10.1016/j.cell.2020.11.020
6. Korber B, Fischer WM, Gnanakaran S, et al.;I-Sheffield COVID-19 Genomics Group.Ukulandelela izinguquko ku-SARS-CoV-2 spike: ubufakazi bokuthi i-D614G inyusa ukutheleleka kwegciwane le-COVID-19.Iseli
2020;182:812–27.PMID:32697968 https://doi.org/10.1016/j.cell.2020.06.043
7. McCarthy KR, Rennick LJ, Namnulli S, et al.Ukususwa kwemvelo ku-SARS-CoV-2 spike glycoprotein kushayela amasosha omzimba ukubaleka.i-bioRxiv [Ukuphrinta kwangaphambili kuthunyelwe ku-inthanethi Novemba 19, 2020].https://www.biorxiv.org/content/
10.1101/2020.11.19.389916v18.I-Washington NL, White S, Schibor KM, Cirulli ET, Bolze A, Lu JT.S amaphethini okuyeka kofuzo ekuhlolweni kwe-SARS-CoV-2 aphakamisa ukusabalala kokuguqulwa kwe-H69del/V70del e-US.medRxiv [Preprint ithunyelwe ku-inthanethi Disemba 30, 2020].https://www.medrxiv.org/content/10.1101/2020.12.24.20248814v1
9. Weisblum Y, Schmidt F, Zhang F, et al.Balekela ekunciphiseni amasosha omzimba ngokuhlukahluka kwamaprotheni e-SARS-CoV-2.I-eLife 2020;9:e61312.PMID:33112236 https://doi.org/10.7554/eLife.61312
10. Greaney AJ, Loes AN, Crawford KHD, et al.Imephu ebanzi yokuguqulwa kwesizinda se-SARS-CoV-2 receptor-binding ethinta ukuqashelwa ngamasosha omzimba e-polyclonal human serum.i-bioRxiv [Ukuphrinta kuqala okuthunyelwe ku-inthanethi ngoJanuwari 4, 2021].https://www.biorxiv.org/content/10.1101/2020.12.31.425021v1


Isikhathi sokuthumela: Feb-11-2021